idrc has helped graduate 世界杯2022赛程表淘汰赛 undertake thesis research in the field of international development since 1982. the bene fellowship, a bequest from the estate of john g. bene, is offered annually to canadians and permanent residents of canada pursuing master’s or doctoral studies at a canadian university. candidates should have an academic background that combines an interest in forests with social sciences (e.g., forestry/agroforestry/natural resources management/environmental sciences).

the mitacs globalink research internship (gri) is now accepting faculty submissions for summer 2019. gri pairs faculty in canada with international undergrads for 12-week research projects from may to october.

• all disciplines are eligible
• top-ranked senior undergrads travel from australia, brazil, china, france, germany, india, mexico, saudi arabia, tunisia, and ukraine
• faculty can submit multiple projects and re-submit projects from previous years

submit projects by june 13, 2018, at 1 p.m. pt.

questions? visit our website or contact helpdesk@mitacs.ca .

the objective of the idea to innovation (i2i) grants  is to accelerate the pre-competitive development of promising technology originating from the university and college sector and promote its transfer to a new or established canadian company. the i2i grants provide funding to college and university faculty members to support research and development projects with recognized technology transfer potential. this is achieved through defined phases by providing crucial assistance in the early stages of technology validation and market connection.

• innovation for ontario's agricultural systems and soils to reduce phosphorus loss
• sustainable livestock production using precision technologies to support compliance and assurance systems
• disruptive technologies

the responsive grants program enables the law foundation of ontario to fund ideas generated by nonprofit community groups to improve access to justice. each year the program includes two rounds of small grants (up to $15,000).

responsive grants aim to encourage new ideas, approaches, and relationships that can help address emerging needs and connect more people to legal information and supports, especially people who are not currently being reached. these grants have provided seed funding for hundreds of innovative initiatives across ontario.

background
since 2004, the arcticnet network of centres of excellence of canada (nce) has brought together scientists and experts in the natural, human health and social sciences with their partners in inuit organizations, northern communities, governments and the private and public sectors to further our understanding of and help prepare for the impacts and opportunities brought by climate change and modernization in the arctic. further details on arcticnet’s current mandate, objectives and research program are available on our website.

in order to provide the best possible information to address this challenge, a renewed arcticnet will broaden its scope to include not only the coastal and marine arctic, but also the territorial arctic and subarctic regions.

call for letters of intent (loi)
this call for lois aims to define the range of projects, of up to 3 years in duration, for a renewed arcticnet academic-led research program. retained lois will demonstrate the potential breadth and depth of the science program in a renewed arcticnet research strategy. the call is open to arcticnet network investigators wishing to renew their research during cycle iii (2019-2024), as well as to all other eligible northern-focused canadian researchers (see eligibility criteria ). new applicants and collaborators from centres of excellence in northern research and not previously engaged in arcticnet are strongly encouraged to apply.

on behalf of brain canada foundation and als canada, we would be grateful if you could distribute the details of this trainee competition to faculty members and graduate 世界杯2022赛程表淘汰赛 performing research in fields related to als.

briefly, this program is targeting trainees within the first 3 years (phd 世界杯2022赛程表淘汰赛 ) or 2 years (postdoctoral researchers) of their position, who are carrying out research at an eligible canadian institution, and would support them for up to 3 years.

the deadline for full applications will be may 25, 2018 (16:00-est).  please refer to the request for applications for additional details (https://braincanada.ca/for-researchers/).

thank you,

brain canada programs team

fy18 ocrp program announcements and general application instructions for the following award mechanisms are posted on grants.gov. 

as directed by the office of the assistant secretary of defense for health affairs, the defense health agency (dha) j9, research and development directorate, manages the defense health program research, development, test, and evaluation appropriation.  the managing agent for the anticipated program announcements/funding opportunities is the congressionally directed medical research programs (cdmrp).

the mission of the ocrp is to support patient-centered research to prevent, detect, treat, and cure ovarian cancer to enhance the health and well-being of service members, veterans, retirees, their family members, and all women impacted by this disease.

http://cdmrp.army.mil/funding/ocrp

clinical development award – letter of intent due july 25, 2018

• must be an independent investigator at or above the level of assistant professor (or equivalent).
• supports the translation of promising preclinical findings into products for clinical applications, including prevention, detection, diagnosis, treatment, or quality of life.
• near-term impact is expected.

·         preclinical studies in animals are not allowed.

·         small-scale clinical trials (phase 0, phase 1, pilot), studies enriching a clinical trial, and projects related to or associated with ongoing or completed clinical trials are allowed.

·         preliminary data are required.

·         optional nested early-career investigator (eci):  applications proposing clinical trials and having an eci thatmeets the criteria outlined in the program announcement/funding opportunity will qualify for a higher level of funding.

• new: submission of a letter of intent (loi) is required prior to full application submission.
• maximum funding of $600,000 for direct costs (plus indirect costs).
• with eci option the maximum funding is $800,000 for direct costs (plus indirect costs).
• maximum period of performance is 3 years.

omics consortium development award – letter of intent due july 25, 2018

• must be an independent investigator at the associate professor level or above (or equivalent)

·         supports a multi-institutional research effort conducted by leading cancer researchers and advocates that focuses on the origin of ovarian cancer, with a focus on early detection and screening.

·         funds support assembling consortium members and laying the groundwork for the research project, including proof of concept.

·         ovarian cancer advocate(s) are required on the research team.

·         funded applicants will be eligible to compete for the consortium award, which will support the execution of the full research project and is anticipated to be offered in fy20, pending availability of funds.

• new: submission of a letter of intent (loi) is required prior to full application submission
• maximum funding of $400,000 for direct costs (plus indirect costs). 
• period of performance not to exceed 2 years.

investigator-initiated research award – preapplication due may 30, 2018

• must be an independent investigator at or above the level of assistant professor (or equivalent).

·         supports meritorious basic and clinically oriented research in ovarian cancer.

·         impact is an important review criterion.

·         preliminary data are required.

·         clinical trials are not allowed. 

• pre-application is required; application is by invitation only.
• maximum funding of $450,000 for direct costs (plus indirect costs).
• maximum period of performance is 3 years.

ovarian cancer academy award – early-career investigator – letter of intent due july 25, 2018

• must be within 3 years of his/her last postdoctoral research position (ph.d.) or clinical fellowship (m.d.), or equivalent as of the full application submission deadline.  a letter attesting to eligibility is required.

·         supports the addition of new early-career investigators to the unique, interactive virtual academy providing intensive mentoring, national networking, and a peer group for junior faculty.

·         early-career investigators whose ability to commit to conducting ovarian cancer research is limited by lack of resources or other overwhelming obstacles are encouraged to apply.

·         a designated mentor who is an experienced ovarian cancer researcher with ovarian cancer funding is required.

·         a designated mentor may only mentor one early-career investigator candidate.

·         the designated mentor is not required to be at the same institution as the early-career investigator.

·         preliminary data are required.

·         new: clinical trials are allowed.

• new: submission of a letter of intent is required prior to full application submission.
• maximum funding of $725,000 for direct costs (plus indirect costs).
• maximum period of performance is 4 years.

pilot award – preapplication due may 30, 2018

• investigators at or above the postdoctoral level (or equivalent).

·         supports innovative, high-risk/high-reward research that could ultimately lead to critical discoveries or major advancements that will drive the field of ovarian cancer research forward.

·         innovation and impact are important review criteria.

·         goal is to develop preliminary data; thus, preliminary data are not required, but are allowed.

·         clinical trials are not allowed.

• pre-application is required and blinded; application submission is by invitation only.
• maximum funding of $250,000 for direct costs (plus indirect costs).
• maximum period of performance is 2 years.

a pre-application is required and must be submitted through the electronic biomedical research application portal at https://ebrap.org prior to the pre-application deadline.  all applications must conform to the final program announcements and general application instructions available for electronic downloading from the grants.gov website.  the application package containing the required forms for each award mechanism are also on grants.gov.  a listing of all cdmrp funding opportunities can be obtained on the grants.gov website by performing a basic search using cfda number 12.420. 

applications must be submitted through the federal government’s single-entry portal, grants.gov.  .  for email notification when program announcements are released, go to the cdmrp website (http://cdmrp.army.mil) and select subscribe to funding opportunities & program communications.  for more information about the ocrp or other cdmrp-administered programs, please visit the cdmrp website (http://cdmrp.army.mil).

fy18 alsrp program announcements and general application instructions for the following award mechanisms are posted on the grants.gov website.

as directed by the office of the assistant secretary of defense for health affairs, the defense health agency (dha), j9 research and development directorate manages the defense health program (dhp) research, development, test and evaluation (rdt&e) appropriation. the managing agent for the anticipated program announcements/funding opportunities is the congressionally directed medical research programs (cdmrp).

the mission of the alsrp is to fund innovative pre-clinical research to develop new treatments for als for the benefit of service members, veterans, and the general public.

http://cdmrp.army.mil/funding/alsrp

the following mechanisms are planned for release:

therapeutic development award – preproposal due june 22, 2018

• independent investigators at all academic levels
• pre-application is required; full application submission is by invitation only
• supports post-discovery, preclinical development of therapeutics for als
• preliminary data, including identify and purity of an identified bioactive compound(s), are required
• types of efforts that will be supported include:
  • confirmation of candidate therapeutics obtained from screening or by other means
  • validation of early pilot studies in multiple model systems and/or replicating preliminary data with more time points or additional doses
  • optimization of potency and pharmacology, studies of formulation, stability and production methods based on good manufacturing practices
  • investigational new drug (ind)-enabling studies
• clinical trials are not allowed
• collaboration with industry is encouraged
• does not support screening or development of screens or models
• new! the following option, with additional funding for qualified applications, is being offered:
• therapeutic relevance option supports development of markers that will improve the drug development process in parallel with the main therapeutic advancement effort.
• applicants must submit a therapeutic relevance statement that clearly describes how the marker is quantifiable and has potential to improve the efficacy of the therapy development process.
• application to this option is not a requirement for tda submission
• a tda application requesting the higher level of funding that does not meet the specified criteria may be funded at the lower level
• standard award maximum funding of $1,000,000 for direct costs
• standard award with option:
  • if applying for the therapeutic relevance option, maximum funding of up to $1,250,000 for direct costs
• maximum period of performance is 2 years
• indirect costs may be proposed in accordance with the institution’s negotiated rate agreement.

therapeutic idea award – preproposal due june 22, 2018

• independent investigators at all academic levels
• pre-application is required; full application submission is by invitation only.
• supports new ideas aimed at drug or treatment discovery that are still in the early stages of development
• preliminary data are not required
• types of efforts that will be supported include:

o    exploitation of pathways known to be relevant to als for the purpose of improving treatment and/or advancing a novel treatment modality

o    development, modification, and use of high-throughput screens and novel model systems to define or assess lead compounds

o    projects that focus primarily on investigating the pathophysiology of als are outside of the scope of this announcement

a pre-application is required and must be submitted through the electronic biomedical research application portal (ebrap) at https://ebrap.org prior to the pre-application deadline. all applications must conform to the final program announcements and general application instructions available for electronic downloading from the grants.gov website. the application package containing the required forms for each award mechanism will also be found on grants.gov. a listing of all cdmrp funding opportunities can be obtained on the grants.gov website by performing a basic search using cfda number 12.420.

applications must be submitted through the federal government’s single-entry portal, grants.gov. for email notification when program announcements are released, subscribe to program-specific news and updates under “email subscriptions” on the ebrap homepage at https://ebrap.org. for more information about the alsrp or other cdmrp-administered programs, please visit the cdmrp website (http://cdmrp.army.mil).

in recognition of the growing importance of good governance to all canadian institutions, the canadian foundation for governance research is offering annual bertram scholarships of $15,000 each to phd 世界杯2022赛程表淘汰赛 registered at canadian universities.  the scholarship will support the work of 世界杯2022赛程表淘汰赛 who are conducting research into organisational governance as part of their doctoral research project. 

to qualify for the scholarship, the doctoral research project should focus on a topic directly related to organizational governance, including for example:

• the importance of organisational governance in enabling effective decision-making and improved functioning of canadian institutions ;
• governance issues of interest to canadian boards of public, private, government-agency and not-for-profit organizations;
• the role of corporate governance in enabling positive societal impacts;
• organisational governance best practices through the canadian perspective.

the following are examples of relevant topics, although by no means an exhaustive list:

• diversity beyond gender
• long-termism/sustainability
• ethics/codes of conduct/conflict of interest
• oversight of corporate culture
• cybersecurity/ it governance
• board’s role in innovation

for full details on the bertram scholarship, visit the cfgr website. the deadline for application is may 22, 2018.